Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety

(2020) Charles E. Leonard et al.   Cardiovascular Diabetology

Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association

(2020) James E. Tisdale et al.   CIRCULATION

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Strategies to increase cardioprotection through cardioprotective chemokines in chemotherapy-induced cardiotoxicity

(2018) Habib Haybar et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database

(2018) Hanna K. Welch et al.   PHARMACOTHERAPY

Gemcitabine-Induced Supraventricular Tachycardia

(2018) Oshrat E Tayer-Shifman et al.   TUMORI

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

(2018) Graham H Jackson et al.   LANCET ONCOLOGY

Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group

(2017) Johannes J.M. Kwakman et al.   EUROPEAN JOURNAL OF CANCER

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

(2017) Nicholas S. Downing et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

(2016) Giuseppe Curigliano et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cardio-Oncology

(2016) Carrie G. Lenneman et al.   CIRCULATION RESEARCH

Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy

(2016) Clelia Madeddu et al.   Journal of Cardiovascular Medicine

Myocardial infarction, symptomatic third degree atrioventricular block and pulmonary embolism caused by thalidomide: a case report

(2015) Shengyu Zhang et al.   BMC Cardiovascular Disorders

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

(2015) D. Cardinale et al.   CIRCULATION

Cancer Chemotherapy and Cardiac Arrhythmias: A Review

(2015) Juan Tamargo et al.   DRUG SAFETY

Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling

(2015) Santiago Vilar et al.   PLoS One

Global epidemiology of atrial fibrillation

(2014) Faisal Rahman et al.   Nature Reviews Cardiology

Data Mining of the Public Version of the FDA Adverse Event Reporting System

(2013) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

Drug-Induced Atrial Fibrillation

(2012) Yaman Kaakeh et al.   DRUGS

Antineoplastic drug-induced bradyarrhythmias

(2012) Carla Minoia et al.   Expert Opinion On Drug Safety

Management of Patients with Drug-Induced Atrioventricular Block

(2012) DAMIRBEK OSMONOV et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

(2011) Jean-Louis Montastruc et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports

(2011) Nicholas P Tatonetti et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis

(2010) Jen A. Tan et al.   INTENSIVE CARE MEDICINE

Introducing a new entity: chemotherapy-induced arrhythmia

(2009) M. Guglin et al.   EUROPACE

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

Breaking the News or Fueling the Epidemic? Temporal Association between News Media Report Volume and Opioid-Related Mortality

(2009) Nabarun Dasgupta et al.   PLoS One

Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy

(2007) Panagiotis Korantzopoulos et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY